CIK 0001739174 · Non-accelerated filer<br>Smaller reporting company
Tessera Defense & Homeland Security Inc.
Sign in to watch- Ticker
- HLSQ
- Exchange
- NYSE
- Industry
- Services-Prepackaged Software
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823364020
- Phone
- 972 545610935
- Business address
- 850 NEW BURTON ROAD, SUITE 201, DOVER, DE, 19904
- Former names
- BiomX Inc., Chardan Healthcare Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-17 | Yeganeh Reuven Director | Conversion | +530,000 | $2.00 | $1.1M | 530,000 |
| 2026-03-17 | Yeganeh Reuven Director | Sale | −530,000 | $5.00 | $2.6M | 0 |
| 2026-03-17 | Yeganeh Reuven Director | Conversion · Series Y Convertible Preferred Stock | −1,060 | 0 | ||
| 2026-03-16 | Yeganeh Reuven Director | Conversion | +450,000 | $2.00 | $900K | 450,000 |
| 2026-03-16 | Yeganeh Reuven Director | Sale | −450,000 | $5.00 | $2.3M | 0 |
| 2026-03-16 | Yeganeh Reuven Director | Conversion · Series Y Convertible Preferred Stock | −900 | 1,060 | ||
| 2026-03-16 | Yeganeh Reuven Director | Sale · Common Stock Purchase Warrants | −1,300,000 | $5.00 | $6.5M | 2,000,000 |
| 2026-03-16 | Yeganeh Reuven Director | Sale · Common Stock Purchase Warrants | −2,000,000 | $5.24 | $10.5M | 1,700,000 |
| 2026-03-16 | Yeganeh Reuven Director | Sale · Common Stock Purchase Warrants | −1,700,000 | $4.76 | $8.1M | 0 |
| 2026-03-13 | Yeganeh Reuven Director | Conversion | +370,000 | $2.00 | $740K | 370,000 |
| 2026-03-13 | Yeganeh Reuven Director | Sale | −370,000 | $5.00 | $1.9M | 0 |
| 2026-03-13 | Yeganeh Reuven Director | Conversion · Series Y Convertible Preferred Stock | −740 | 1,960 | ||
| 2026-03-12 | Yeganeh Reuven Director | Sale | −300,000 | $5.00 | $1.5M | 0 |
| 2026-03-12 | Yeganeh Reuven Director | Conversion · Series Y Convertible Preferred Stock | −600 | 2,700 | ||
| 2026-03-11 | Yeganeh Reuven Director | Conversion | +300,000 | $2.00 | $600K | 30,000 |
| 2025-04-21 | Flynn James E Director | Grant or award · Warrants | +1,611,864 | 1,611,864 | ||
| 2025-04-21 | Flynn James E Director | Grant or award · Warrants | +1,611,864 | 1,611,864 | ||
| 2025-04-14 | Merril Gregory Louis Director | Grant or award · Common Stock Options - right to Buy | +17,600 | 17,600 | ||
| 2025-04-14 | Bassan Merav Chief Development Officer | Grant or award | +79,597 | 79,597 | ||
| 2025-04-14 | Bassan Merav Chief Development Officer | Grant or award · Common Stock Options - right to Buy | +95,000 | 95,000 |
Page 1 of 12 · 240 trades